Are Dire Wolves really back? We give our take on Colossal Biosciences’ latest announcement about the de-extinction of Dire Wolves including some thoughts on their approach and some of the broader implications of their work. In other stories, we discuss the early impact of the Trump administration’s tariffs on biotech as well as the growing alarm in the scientific community in the wake of sweeping layoffs and leadership departures at the FDA, CDC, and NIH. We also share news from recent scientific conferences and meetings that we’ve attended as well as an interesting study that used human cell maps to shed new light on pediatric bone cancer.
Listed below are links to the GEN stories referenced in this episode of Touching Base.
Plex Research Partners with Ginkgo Bioworks to Apply AI-Based Search Engine to Drug Discovery
By Uduak Thomas, GEN, April 8, 2025
Danaher-IGI Beacon for CRISPR Cures Celebrates One-Year Anniversary
By Fay Lin, PhD, GEN, March 28, 2025
Human Cell Maps Uncover Insights in Pediatric Bone Cancer
By GEN, April 10, 2025
StockWatch: Biopharma Funds Tumble with Wall Street as Industry Spared from Worst of Tariffs—for Now
By Alex Philippidis, GEN Edge, April 6, 2025
FDA, NIH, CDC Stagger as HHS Axe Falls, Eliminating 10,000 Jobs
By Alex Philippidis, GEN Edge, April 1, 2025
Industry Voices Alarm as Peter Marks Departs FDA
By Kevin Davies, PhD, and Alex Philippidis, GEN Edge, March 30, 2025
The State of Multiomics & NGS 2025
Broadcast Date: Wednesday, April 23, 2025
Resurrection Genomics: A Conversation with Colossal’s Chief Biology Officer Eriona Hysolli
The State of Omics 2024, April 17, 2024
